Current status of mesenchymal stem cell therapy and bone marrow transplantation in IBD

Digestive Diseases

Volumn 30, Issue 4, 2012, Pages 387-391

  Ricart, Elena ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Bone marrow transplantation; Cell therapy; Crohn's disease; Mesenchymal stem cells

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; THYMOCYTE ANTIBODY;

ANUS FISTULA; ARTICLE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CROHN DISEASE; DISEASE ACTIVITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOBILIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; RELAPSE; REMISSION; SURGICAL APPROACH; TISSUE INJURY;

ANIMALS; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS;

EID: 84863942494     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000338134     Document Type: Article

References (22)

1. Peyrin-Biroulet L, Loftus EV Jr., Colombel JF, Sandborn WJ: The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010; 105: 289-297.
2. Chamberlain G, Fox J, Ashton B, Middleton J: Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
3. Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, et al: Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum 2006; 54: 3750-3760.
4. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, et al: Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2005; 35: 869-879.
5. Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, et al: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study. Blood 2007; 110: 1388-1396.
6. Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, et al: Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295: 527-535.
7. Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A, et al: Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 2005; 128: 552-563.
8. Burt RK, Craig RM, Milanetti F, Quigley K, Gozdziak P, Bucha J, et al: Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term followup. Blood 2010; 116: 6123-6132.
9. Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M, et al: Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut 2008; 57: 211-217.
10. Scime R, Cavallaro AM, Tringali S, Santoro A, Rizzo A, Montalbano L, et al: Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn's disease refractory to immunosuppressive and immunomodulator therapy. Inflamm Bowel Dis 2004; 10: 892-894.
11. Kreisel W, Potthoff K, Bertz H, Schmitt-Graeff A, Ruf G, Rasenack J, et al: Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant 2003; 32: 337-340.
12. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, Noyan F, et al: Inflammatory bowel disease and mutations affecting the interleukin-10 receptor, N Engl J Med 2009; 361: 2033-2045.
13. Aggarwal S, Pittenger MF: Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-1822.
14. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al: Human bone marrow stromal cells suppress Tlymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-3843.
15. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al: Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722-3729.
16. Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, et al: Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of selecta muscle and dermis derived from fetal, adult and geriatric donors. Anat Rec 2001; 264: 51-62.
17. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-2402.
18. Bruder SP, Jaiswal N, Haynesworth SE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64: 278-294.
19. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al: Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-1586.
20. Duijvestein M, Vos ACW, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, et al: Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010; 59: 1662-1669.
21. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, et al: Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulizing Crohn's disease patients. Gut 2011; 60: 788-798.
22. Okamoto R, Matsumoto T, Watanabe M: Regeneration of the intestinal epithelia: regulation of bone marrow-derived epithelial cell differentiation towards secretory lineage cells. Human Cell 2006; 19: 71-75.